The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
Abstract
Phosphate binders that contain aluminum are frequently prescribed to treat hyperphosphatemia in patients with chronic renal failure, but an accumulation of aluminum can lead to osteomalacia. To evaluate the efficacy of calcium carbonate as an alternative phosphate binder, we studied 20 patients maintained on dialysis during three consecutive periods. In period 1, the patients took aluminum hydroxide for a month (mean dose, 5.6 g per day; range, 1.5 to 14.0). In period 2, they took no phosphate binders for a month, and in period 3, they took calcium carbonate (Os-Cal) for two months (mean dose, 8.5 g per day; range, 2.5 to 17). The mean (+/- SE) serum calcium level during period 1 was 9.6 +/- 0.2 mg per deciliter; this decreased slightly (to 9.3 +/- 0.1) during period 2 and increased to 10.0 +/- 0.2 during period 3. The mean (+/- SE) serum phosphorus level during period 1 was 4.8 +/- 0.1 mg per deciliter; this increased to 7.3 +/- 0.3 during period 2, but returned to the control value (4.8 +/- 0.2) during period 3. Six of the 20 patients continued to need aluminum hydroxide during period 3 for satisfactory control of hyperphosphatemia. Calcium carbonate successfully lowered serum phosphorus levels and raised serum calcium levels in the majority of our patients, thereby confirming that this agent may be a satisfactory substitute for traditional phosphate binders that contain aluminum. The possibility that long-term treatment could cause such side effects as metastatic calcification will require further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus
Tanaka, Y., & Deluca, H. F. (1973) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(73)90010-6 · Cited by 780
Slatopolsky, E., Weerts, C., Thielan, J., Horst, R., Harter, H., & Martin, K. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111639 · Cited by 684
Self-citationSilver, J., Russell, J., & Sherwood, L. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4270 · Cited by 495
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
Slatopolsky, E., Caglar, S., Pennell, J. P., Taggart, D. D., Canterbury, J. M., Reiss, E., & Bricker, N. S. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106517 · Cited by 481
Self-citationRAISZ, L. G. (1969) · Endocrinology · doi:10.1210/endo-85-3-446 · Cited by 410
Portale, A. A., Booth, B. E., Halloran, B. P., & Morris, R. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111365 · Cited by 353
Ott, S. M., Maloney, N. A., Coburn, J. W., Alfrey, A. C., & Sherrard, D. J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209163071202 · Cited by 353
Hruska, K. A., Kopelman, R., Rutherford, W. E., Klahr, S., Slatopolsky, E., Greenwalt, A., Bascom, T., & Markham, J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108077 · Cited by 294
Self-citationBone Aluminum and Histomorphometric Features of Renal Osteodystrophy*
HODSMAN, A. B., SHERRARD, D. J., ALFREY, A. C., OTT, S., BRICKMAN, A. S., MILLER, N. L., MALONEY, N. A., & COBURN, J. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-3-539 · Cited by 272
HYPERALUMINqMIA FROM ALUMINIUM RESINS IN RENAL FAILURE
BERLYNE, G. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90113-3 · Cited by 241
Cited by
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Sitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 542
Phosphorus Binders and Survival on Hemodialysis
Isakova, T., Gutie[Combining Acute Accent]rrez, O. M., Chang, Y., Shah, A., Tamez, H., Smith, K., Thadhani, R., & Wolf, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060609 · Cited by 375
Slatopolsky, E. A., Burke, S. K., & Dillon, M. A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00240.x · Cited by 302
Self-citationChertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.12.2907 · Cited by 296
Self-citation
Metadata
- Authors
- Slatopolsky, E., Weerts, C., Lopez-Hilker, S., Norwood, K., Zink, M., Windus, D., & Delmez, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-07-17
- Volume
- 315
- Issue
- 3
- Pages
- 157-161
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2320589260
- Cited by
- 379
- References
- 20
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis. https://app.cochat.ai/papers/10.1056/nejm198607173150304
- The paper
- Slatopolsky, E., Weerts, C., Lopez-Hilker, S., Norwood, K., Zink, M., Windus, D., & Delmez, J. (1986). Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis. New England Journal of Medicine. https://doi.org/10.1056/nejm198607173150304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.